Rachael Lester's most recent trade in CytomX Therapeutics Inc was a trade of 50,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Feb. 2, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| CytomX Therapeutics Inc | Rachael Lester | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Feb 2026 | 50,000 | 50,000 | - | - | Stock Option (Right to Buy) | |
| CytomX Therapeutics Inc | Rachael Lester | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Feb 2026 | 50,000 | 50,000 | - | - | Performance Stock Units (PSUs) | |
| CytomX Therapeutics Inc | Rachael Lester | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Feb 2026 | 20,000 | 20,000 (0%) | 0% | 0 | Common Stock | |
| CytomX Therapeutics Inc | Rachael Lester | Chief Business Officer | 20 Oct 2025 | 650,000 | 650,000 | - | - | Stock Option (Right to Buy) |